Brief: Essex Bio Technology unit enters into subscription agreement
April 12 (Reuters) - Essex Bio-Technology Ltd 1061.HK : * Essex Bio Investment entered into the subscription agreement with ACI * Essex Bio investment conditionally agreed to subscribe for subscribed preferred shares at consideration of approximately US$5.0 million * Source text for Eikon ID:nHKS6knRxz ((For more news, please click here 1061.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Essex Bio-Technology
See all newsHong Kong's Essex Bio-Technology H1 revenue falls
Brief: Essex Bio-Technology Posts HY Profit Of HK$110.7 MLN
Brief: Essex Bio-Technology Expects 10% Revenue And 30% Profit Decrease For HY
Brief: Shanghai Henlius Biotech Says Phase 3 Study Of HLX04-O For WAMD Meets Primary Endpoint
Brief: Essex Bio-Technology Posts Final Dividend Of HK$0.07 Per Share